Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1995-6-27
pubmed:abstractText
Studies on the molecular basis of neurological and psychiatric disorders often rely on the precise determination of specific proteins in brain tissues. In this study, we have developed a method for measuring the levels of the neural-specific growth-associated protein, GAP-43, in human postmortem brain specimens. This rapid and quantitative method is based on immunodetection procedures. Briefly, synaptosomal plasma membranes (SPMs) are deposited onto polyvinylidene difluoride (PVDF) membranes via a dot-blotting apparatus, followed by specific GAP-43 detection using a monospecific polyclonal antibody. Overall, the dot-blot procedure provided several advantages over Western blots and one-dimensional and two-dimensional polyacrylamide gels. The assays were more sensitive, reproducible, and allowed the rapid and simultaneous determination of multiple samples. Using this technique, we examined the levels of the GAP-43 protein in Brodmann's areas 17, 20, and 10 of schizophrenic and age-, sex-, and postmortem interval (PMI) matched controls. These studies revealed an increase in the levels of GAP-43 in visual association and frontal cortices (areas 20 and 10) of schizophrenic brains. Given the relationship of GAP-43 expression with the establishment and remodeling of neural connections, our results support the hypothesis that schizophrenia is associated with a perturbed organization of synaptic connections in associative areas of the human brain.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1044-7393
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1-11
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:7755843-Adult, pubmed-meshheading:7755843-Aged, pubmed-meshheading:7755843-Animals, pubmed-meshheading:7755843-Blotting, Western, pubmed-meshheading:7755843-Brain, pubmed-meshheading:7755843-Brain Chemistry, pubmed-meshheading:7755843-Cell Membrane, pubmed-meshheading:7755843-Electrophoresis, Gel, Two-Dimensional, pubmed-meshheading:7755843-Electrophoresis, Polyacrylamide Gel, pubmed-meshheading:7755843-Female, pubmed-meshheading:7755843-GAP-43 Protein, pubmed-meshheading:7755843-Haloperidol, pubmed-meshheading:7755843-Humans, pubmed-meshheading:7755843-Immunoblotting, pubmed-meshheading:7755843-Male, pubmed-meshheading:7755843-Membrane Glycoproteins, pubmed-meshheading:7755843-Middle Aged, pubmed-meshheading:7755843-Nerve Tissue Proteins, pubmed-meshheading:7755843-Neurofilament Proteins, pubmed-meshheading:7755843-Postmortem Changes, pubmed-meshheading:7755843-Rats, pubmed-meshheading:7755843-Rats, Sprague-Dawley, pubmed-meshheading:7755843-Reference Values, pubmed-meshheading:7755843-Reproducibility of Results, pubmed-meshheading:7755843-Schizophrenia, pubmed-meshheading:7755843-Sensitivity and Specificity, pubmed-meshheading:7755843-Synaptosomes, pubmed-meshheading:7755843-Visual Cortex
pubmed:year
1995
pubmed:articleTitle
Increased levels of GAP-43 protein in schizophrenic brain tissues demonstrated by a novel immunodetection method.
pubmed:affiliation
Department of Chemistry, University of New Mexico School of Medicine, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't